Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Reuters Health Features Dr. Howard Ross’s Perspective on New Ulcerative Colitis Research

View All News

Howard M. Ross, MD, FACS, FASCRS, Professor of Clinical Surgery and Program Director of the General Surgery Residency Program at the Lewis Katz School of Medicine at Temple University and Chief of the Division of Colorectal Surgery and Surgical Director of the Digestive Disease Center at Temple University Hospital, provided perspective to Reuters Health about new research published in Science Immunology about cells that may be responsible for persistent inflammation seen in ulcerative colitis. Dr. Ross was not involved in the research. The Reuters Health article was picked up by Medscape.